A gain-of-function sodium channel β2-subunit mutation in painful diabetic neuropathy

on behalf of the Propane Study Group

Research output: Contribution to journalArticle

Abstract

Diabetes mellitus is a global challenge with many diverse health sequelae, of which diabetic peripheral neuropathy is one of the most common. A substantial number of patients with diabetic peripheral neuropathy develop chronic pain, but the genetic and epigenetic factors that predispose diabetic peripheral neuropathy patients to develop neuropathic pain are poorly understood. Recent targeted genetic studies have identified mutations in α-subunits of voltage-gated sodium channels (Na v s) in patients with painful diabetic peripheral neuropathy. Mutations in proteins that regulate trafficking or functional properties of Na v s could expand the spectrum of patients with Na v -related peripheral neuropathies. The auxiliary sodium channel β-subunits (β1–4) have been reported to increase current density, alter inactivation kinetics, and modulate subcellular localization of Na v . Mutations in β-subunits have been associated with several diseases, including epilepsy, cancer, and diseases of the cardiac conducting system. However, mutations in β-subunits have never been shown previously to contribute to neuropathic pain. We report here a patient with painful diabetic peripheral neuropathy and negative genetic screening for mutations in SCN9A, SCN10A, and SCN11A—genes encoding sodium channel α-subunit that have been previously linked to the development of neuropathic pain. Genetic analysis revealed an aspartic acid to asparagine mutation, D109N, in the β2-subunit. Functional analysis using current-clamp revealed that the β2-D109N rendered dorsal root ganglion neurons hyperexcitable, especially in response to repetitive stimulation. Underlying the hyperexcitability induced by the β2-subunit mutation, as evidenced by voltage-clamp analysis, we found a depolarizing shift in the voltage dependence of Na v 1.7 fast inactivation and reduced use-dependent inhibition of the Na v 1.7 channel.

Original languageEnglish
JournalMolecular Pain
Volume15
DOIs
Publication statusPublished - 1 May 2019

Fingerprint

Diabetic Neuropathies
Sodium Channels
Peripheral Nervous System Diseases
Mutation
Neuralgia
Voltage-Gated Sodium Channels
Heart Neoplasms
Asparagine
Genetic Testing
Spinal Ganglia
Protein Transport
Epigenomics
Aspartic Acid
Chronic Pain
Heart Diseases
Epilepsy
Diabetes Mellitus
Neurons
Health

Keywords

  • Diabetic neuropathy
  • neuropathic pain
  • sodium channel beta-subunits
  • voltage-gated sodium channels

ASJC Scopus subject areas

  • Molecular Medicine
  • Cellular and Molecular Neuroscience
  • Anesthesiology and Pain Medicine

Cite this

A gain-of-function sodium channel β2-subunit mutation in painful diabetic neuropathy. / on behalf of the Propane Study Group.

In: Molecular Pain, Vol. 15, 01.05.2019.

Research output: Contribution to journalArticle

@article{fed29417535c44c89066495e8fc1235b,
title = "A gain-of-function sodium channel β2-subunit mutation in painful diabetic neuropathy",
abstract = "Diabetes mellitus is a global challenge with many diverse health sequelae, of which diabetic peripheral neuropathy is one of the most common. A substantial number of patients with diabetic peripheral neuropathy develop chronic pain, but the genetic and epigenetic factors that predispose diabetic peripheral neuropathy patients to develop neuropathic pain are poorly understood. Recent targeted genetic studies have identified mutations in α-subunits of voltage-gated sodium channels (Na v s) in patients with painful diabetic peripheral neuropathy. Mutations in proteins that regulate trafficking or functional properties of Na v s could expand the spectrum of patients with Na v -related peripheral neuropathies. The auxiliary sodium channel β-subunits (β1–4) have been reported to increase current density, alter inactivation kinetics, and modulate subcellular localization of Na v . Mutations in β-subunits have been associated with several diseases, including epilepsy, cancer, and diseases of the cardiac conducting system. However, mutations in β-subunits have never been shown previously to contribute to neuropathic pain. We report here a patient with painful diabetic peripheral neuropathy and negative genetic screening for mutations in SCN9A, SCN10A, and SCN11A—genes encoding sodium channel α-subunit that have been previously linked to the development of neuropathic pain. Genetic analysis revealed an aspartic acid to asparagine mutation, D109N, in the β2-subunit. Functional analysis using current-clamp revealed that the β2-D109N rendered dorsal root ganglion neurons hyperexcitable, especially in response to repetitive stimulation. Underlying the hyperexcitability induced by the β2-subunit mutation, as evidenced by voltage-clamp analysis, we found a depolarizing shift in the voltage dependence of Na v 1.7 fast inactivation and reduced use-dependent inhibition of the Na v 1.7 channel.",
keywords = "Diabetic neuropathy, neuropathic pain, sodium channel beta-subunits, voltage-gated sodium channels",
author = "{on behalf of the Propane Study Group} and Matthew Alsaloum and Mark Estacion and Rowida Almomani and Gerrits, {Monique M.} and B{\"o}nhof, {Gidon J.} and Dan Ziegler and Rayaz Malik and Maryam Ferdousi and Giuseppe Lauria and Merkies, {Ingemar S.J.} and Faber, {Catharina G.} and Sulayman Dib-Hajj and Waxman, {Stephen G.}",
year = "2019",
month = "5",
day = "1",
doi = "10.1177/1744806919849802",
language = "English",
volume = "15",
journal = "Molecular Pain",
issn = "1744-8069",
publisher = "BioMed Central",

}

TY - JOUR

T1 - A gain-of-function sodium channel β2-subunit mutation in painful diabetic neuropathy

AU - on behalf of the Propane Study Group

AU - Alsaloum, Matthew

AU - Estacion, Mark

AU - Almomani, Rowida

AU - Gerrits, Monique M.

AU - Bönhof, Gidon J.

AU - Ziegler, Dan

AU - Malik, Rayaz

AU - Ferdousi, Maryam

AU - Lauria, Giuseppe

AU - Merkies, Ingemar S.J.

AU - Faber, Catharina G.

AU - Dib-Hajj, Sulayman

AU - Waxman, Stephen G.

PY - 2019/5/1

Y1 - 2019/5/1

N2 - Diabetes mellitus is a global challenge with many diverse health sequelae, of which diabetic peripheral neuropathy is one of the most common. A substantial number of patients with diabetic peripheral neuropathy develop chronic pain, but the genetic and epigenetic factors that predispose diabetic peripheral neuropathy patients to develop neuropathic pain are poorly understood. Recent targeted genetic studies have identified mutations in α-subunits of voltage-gated sodium channels (Na v s) in patients with painful diabetic peripheral neuropathy. Mutations in proteins that regulate trafficking or functional properties of Na v s could expand the spectrum of patients with Na v -related peripheral neuropathies. The auxiliary sodium channel β-subunits (β1–4) have been reported to increase current density, alter inactivation kinetics, and modulate subcellular localization of Na v . Mutations in β-subunits have been associated with several diseases, including epilepsy, cancer, and diseases of the cardiac conducting system. However, mutations in β-subunits have never been shown previously to contribute to neuropathic pain. We report here a patient with painful diabetic peripheral neuropathy and negative genetic screening for mutations in SCN9A, SCN10A, and SCN11A—genes encoding sodium channel α-subunit that have been previously linked to the development of neuropathic pain. Genetic analysis revealed an aspartic acid to asparagine mutation, D109N, in the β2-subunit. Functional analysis using current-clamp revealed that the β2-D109N rendered dorsal root ganglion neurons hyperexcitable, especially in response to repetitive stimulation. Underlying the hyperexcitability induced by the β2-subunit mutation, as evidenced by voltage-clamp analysis, we found a depolarizing shift in the voltage dependence of Na v 1.7 fast inactivation and reduced use-dependent inhibition of the Na v 1.7 channel.

AB - Diabetes mellitus is a global challenge with many diverse health sequelae, of which diabetic peripheral neuropathy is one of the most common. A substantial number of patients with diabetic peripheral neuropathy develop chronic pain, but the genetic and epigenetic factors that predispose diabetic peripheral neuropathy patients to develop neuropathic pain are poorly understood. Recent targeted genetic studies have identified mutations in α-subunits of voltage-gated sodium channels (Na v s) in patients with painful diabetic peripheral neuropathy. Mutations in proteins that regulate trafficking or functional properties of Na v s could expand the spectrum of patients with Na v -related peripheral neuropathies. The auxiliary sodium channel β-subunits (β1–4) have been reported to increase current density, alter inactivation kinetics, and modulate subcellular localization of Na v . Mutations in β-subunits have been associated with several diseases, including epilepsy, cancer, and diseases of the cardiac conducting system. However, mutations in β-subunits have never been shown previously to contribute to neuropathic pain. We report here a patient with painful diabetic peripheral neuropathy and negative genetic screening for mutations in SCN9A, SCN10A, and SCN11A—genes encoding sodium channel α-subunit that have been previously linked to the development of neuropathic pain. Genetic analysis revealed an aspartic acid to asparagine mutation, D109N, in the β2-subunit. Functional analysis using current-clamp revealed that the β2-D109N rendered dorsal root ganglion neurons hyperexcitable, especially in response to repetitive stimulation. Underlying the hyperexcitability induced by the β2-subunit mutation, as evidenced by voltage-clamp analysis, we found a depolarizing shift in the voltage dependence of Na v 1.7 fast inactivation and reduced use-dependent inhibition of the Na v 1.7 channel.

KW - Diabetic neuropathy

KW - neuropathic pain

KW - sodium channel beta-subunits

KW - voltage-gated sodium channels

UR - http://www.scopus.com/inward/record.url?scp=85065569409&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85065569409&partnerID=8YFLogxK

U2 - 10.1177/1744806919849802

DO - 10.1177/1744806919849802

M3 - Article

VL - 15

JO - Molecular Pain

JF - Molecular Pain

SN - 1744-8069

ER -